| Name | Title | Contact Details |
|---|
Autonomous Solutions, Inc. (ASI) is a leader in industrial vehicle automation, focusing on retrofitting existing equipment with autonomous technology. Founded in 2000 and based in Petersboro, Utah, ASI operates a 100-acre proving ground for robotics testing. The company provides OEM/vendor-independent automation solutions for various sectors, employing between 201 and 500 staff and serving clients across six continents. ASI offers a range of products and services, including the Mobius® Fleet Management System for coordinating autonomous fleets and custom automation kits for vehicles of all sizes. Their solutions cater to multiple industries, such as mining, automotive, agriculture, military, construction, logistics, security, and research. Notable clients include Ford Motor Company, Anglo American, John Deere, and the U.S. Department of Defense. ASI emphasizes all-weather, 24/7 operation, enhancing efficiency and reducing costs in applications like landscaping.
IMUNON is a fully integrated, clinical stage biotechnology company focused on advancing a portfolio of innovative treatments that harness the bodys natural mechanisms to generate safe, effective, and durable responses across a broad array of human diseases. IMUNON has two platform technologies: Our TheraPlas® platform for the development of immunotherapies and other anti-cancer nucleic acid-based therapies and our PLACCINE platform for the development of nucleic acid vaccines for infectious diseases and cancer. The Companys lead clinical program, GEN-1, is a DNA-based immunotherapy for the localized treatment of advanced ovarian cancer currently in Phase II development. GEN-1 works by instructing the body to produce safe and durable levels of powerful cancer fighting molecules, such as interleukin-12 (IL-12) and interferon gamma (IFN-γ), at the tumor site. In addition, we are conducting pre-clinical proof-of-concept studies on a nucleic acid vaccine candidate targeting SARS-CoV-2 virus in order to validate our PLACCINE platform. IMUNONs platform technologies are based on the delivery of nucleic acids with novel synthetic delivery systems that are independent of viral vectors or devices. We will continue to leverage these platforms and to advance the technological frontier of plasmid DNA to better serve patients with difficult to treat conditions.
JELD-WEN is a leading global designer, manufacturer and distributor of high-performance interior and exterior doors, windows, and related building products serving the new construction and repair and remodeling sectors. Headquartered in Charlotte, N.C., the company operates facilities in 16 countries in North America and Europe and employs approximately 18,000 people. Since 1960, the JELD-WEN team has been committed to making quality products that create safe and sustainable environments for customers, associates and local communities. The JELD-WEN family of brands includes JELD-WEN® worldwide, LaCantina™ and VPI™ in North America, and Swedoor® and DANA® in Europe. For more information about JELD-WEN or to join our team, visit https://www.corporate.jeld-wen.com/.
Verge Motorcycles develops and manufactures the worlds most advanced electric superbike. With its patented motor technology and innovative design, Verge challenges conventional ways of thinking with the clear goal of creating the worlds best electric motorcycle from the ground up. Not a motorcycle that looks like yesterday, but a motorcycle that feels like the future.